X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (595) 595
Publication (94) 94
Newspaper Article (28) 28
Book Chapter (10) 10
Newsletter (9) 9
Book Review (7) 7
Magazine Article (2) 2
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rilpivirine (545) 545
humans (370) 370
index medicus (360) 360
hiv infections - drug therapy (252) 252
infectious diseases (209) 209
hiv (191) 191
pharmacology & pharmacy (183) 183
efavirenz (173) 173
hiv-1 - drug effects (156) 156
female (148) 148
male (148) 148
anti-hiv agents - therapeutic use (131) 131
adult (130) 130
hiv infections - virology (121) 121
emtricitabine (114) 114
immunology (114) 114
anti-hiv agents - administration & dosage (109) 109
antiretroviral therapy (109) 109
tenofovir (107) 107
anti-hiv agents - pharmacology (102) 102
microbiology (102) 102
antiviral agents (101) 101
middle aged (101) 101
drug therapy (91) 91
hiv-1 (91) 91
human immunodeficiency virus--hiv (90) 90
pharmacokinetics (90) 90
hiv infection (87) 87
antiretroviral drugs (83) 83
pyrimidines - therapeutic use (82) 82
nitriles - therapeutic use (81) 81
hiv-1 - genetics (80) 80
safety (79) 79
reverse transcriptase inhibitors - pharmacology (75) 75
drug resistance, viral (72) 72
pyrimidines - pharmacology (72) 72
double-blind (71) 71
hiv reverse transcriptase - antagonists & inhibitors (71) 71
treatment outcome (71) 71
etravirine (70) 70
virology (69) 69
anti-hiv agents - adverse effects (68) 68
mutation (68) 68
reverse transcriptase inhibitors - therapeutic use (68) 68
aids/hiv (66) 66
phase-3 (65) 65
analysis (63) 63
nitriles - pharmacology (62) 62
viral load (62) 62
dosage and administration (61) 61
young adult (59) 59
nitriles - administration & dosage (56) 56
pyrimidines - administration & dosage (56) 56
rilpivirine - therapeutic use (56) 56
infection (55) 55
efficacy (54) 54
nitriles - adverse effects (54) 54
pyrimidines - adverse effects (54) 54
reverse-transcriptase inhibitors (54) 54
therapy (54) 54
trial (52) 52
dolutegravir (49) 49
drug combinations (48) 48
drug resistance (48) 48
adults (47) 47
clinical trials (47) 47
health aspects (47) 47
immunodeficiency-virus type-1 (47) 47
research (47) 47
drug-resistance (46) 46
resistance (46) 46
drug therapy, combination (45) 45
drug interactions (43) 43
hiv-1-infected patients (43) 43
rilpivirine - administration & dosage (43) 43
tmc278 (43) 43
anti-hiv agents - pharmacokinetics (42) 42
hiv reverse transcriptase - genetics (42) 42
nevirapine (42) 42
drug resistance, viral - genetics (41) 41
drugs (41) 41
adenine - analogs & derivatives (40) 40
reverse transcriptase inhibitors - chemistry (40) 40
hiv-1 - isolation & purification (38) 38
virus diseases (38) 38
adolescent (37) 37
dna polymerases (37) 37
hiv-1 - enzymology (37) 37
animals (36) 36
hiv reverse transcriptase - metabolism (36) 36
article (35) 35
deoxycytidine - analogs & derivatives (35) 35
pyrimidines - chemistry (35) 35
pyrimidines - pharmacokinetics (35) 35
chemistry, medicinal (34) 34
nitriles - pharmacokinetics (34) 34
aids (33) 33
benzoxazines - therapeutic use (33) 33
genotype (33) 33
highly active antiretroviral therapy (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (615) 615
Spanish (16) 16
German (5) 5
Czech (2) 2
French (2) 2
Chinese (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S144
L'allegement par bitherapie de DTG (Dolutegravir)-RPV (Rilpivirine) est reconnu comme une alternative en deuxieme ligne de traitement chez un PVVIH sans... 
Rilpivirine
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 05/2012, Volume 69, Issue 10, p. 857
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2 - 12
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 12, pp. e569 - e578
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0134430
Objective To assess, in a clinical cohort, the efficacy of switching treatment in virologically-suppressed patients to tenofovir/emtricitabine/rilpivirine as a... 
MULTIDISCIPLINARY SCIENCES | DISOPROXIL FUMARATE | EMTRICITABINE | SINGLE-TABLET REGIMEN | RILPIVIRINE | RPV/TDF/FTC | TENOFOVIR | Tenofovir - blood | Follow-Up Studies | Humans | Middle Aged | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - therapeutic use | Male | Tenofovir - administration & dosage | Anti-HIV Agents - administration & dosage | Rilpivirine - therapeutic use | Rilpivirine - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Anti-HIV Agents - blood | Drug Therapy, Combination | Rilpivirine - administration & dosage | Emtricitabine - administration & dosage | Emtricitabine - therapeutic use | Tenofovir - therapeutic use | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - administration & dosage | Emtricitabine - blood | HIV Infections - drug therapy | Drug Substitution | Viral Load - drug effects | Drug Combinations | Virus diseases | Highly active antiretroviral therapy | Care and treatment | Protease inhibitors | Proteases | DNA polymerases | Health aspects | Emtricitabine | Antiretroviral drugs | RNA-directed DNA polymerase | Viremia | Viruses | Proteinase inhibitors | Signal monitoring | Patients | Switching | Chromatography | Antiretroviral therapy | Tenofovir | Non-nucleoside reverse transcriptase inhibitors | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Scientific imaging | Drug therapy | Mass spectrometry | Drug dosages | Genotypes | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 476 - 10
Journal Article
Journal Article
Science, ISSN 0036-8075, 07/2019, Volume 365, Issue 6451, p. 309
Journal Article
Journal Article
Journal Article
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 11/2017, Volume 13, Issue 11, pp. 1183 - 1192
Introduction: The search for simple, potent, metabolic-friendly and nucleoside/nucleotide sparing antiretroviral regimens has led clinical investigato